BRIEF published on 11/14/2024 at 07:35, 4 months 19 days ago PharmaSGP Sees Strong Revenue Growth in 9M 2024, Raises Full-Year Forecast Revenue Growth Market Strategy 2024 Forecast PharmaSGP OTC Pharmaceuticals
PRESS RELEASE published on 11/14/2024 at 07:30, 4 months 19 days ago PharmaSGP with strong revenues growth in 9M 2024 – revenues forecast for FY 2024 raised PharmaSGP Holding SE reports strong revenue growth in 9 months of 2024, with preliminary figures showing a 17.0% increase compared to the same period last year. FY 2024 revenue forecast raised Financial Results Revenue Growth Pharmaceuticals Forecast PharmaSGP
BRIEF published on 11/05/2024 at 10:12, 4 months 28 days ago Leadership Transition at PharmaSGP Holding SE: Peter Gerckens to Succeed Natalie Weigand as CEO Company Growth OTC Pharmaceuticals Peter Gerckens Natalie Weigand PharmaSGP Leadership Change
PRESS RELEASE published on 11/05/2024 at 10:07, 4 months 28 days ago CEO change at PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as of January 1, 2025 PharmaSGP Holding SE announces CEO change with Peter Gerckens succeeding Natalie Weigand on January 1, 2025. Smooth transition planned for internal succession Succession Plan CEO Change PharmaSGP Holding SE Peter Gerckens Natalie Weigand
BRIEF published on 11/05/2024 at 10:07, 4 months 28 days ago Leadership Change at PharmaSGP Holding SE: Peter Gerckens Appointed CEO Leadership Transition CEO Change PharmaSGP Holding SE Peter Gerckens Natalie Weigand
PRESS RELEASE published on 11/05/2024 at 10:02, 4 months 28 days ago EQS-Adhoc: PharmaSGP Holding SE: Peter Gerckens succeeds Natalie Weigand as Chief Executive Officer PharmaSGP Holding SE appoints Peter Gerckens as new CEO, succeeding Natalie Weigand. Gerckens, currently CCO, will assume the CEO position on January 1, 2025 Supervisory Board PharmaSGP Holding SE CEO Succession Peter Gerckens Natalie Weigand
BRIEF published on 10/01/2024 at 08:20, 6 months 2 days ago PharmaSGP Holding SE Acquires 477,701 Shares Through Repurchase Offer Share Buyback Treasury Shares Capital Reduction PharmaSGP Repurchase Offer
PRESS RELEASE published on 10/01/2024 at 08:15, 6 months 2 days ago PharmaSGP Holding SE has purchased 477,701 own shares through its public share repurchase offer PharmaSGP Holding SE has purchased 477,701 own shares through public share repurchase offer. The company's acceptance ratio is approximately 80.37% Share Buyback Treasury Shares Public Offer PharmaSGP Holding Acceptance Ratio
BRIEF published on 09/12/2024 at 08:20, 6 months 21 days ago PharmaSGP Continues Dynamic Growth Path in First Half of 2024 Revenue Growth International Expansion PharmaSGP OTC Pharmaceuticals 2024 Financials
BRIEF published on 09/12/2024 at 08:15, 6 months 21 days ago PharmaSGP Holding SE Announces Share Repurchase Program Share Repurchase Acceptance Period PharmaSGP Holding SE 594,405 Shares EUR 21.45
Published on 04/03/2025 at 11:00, 1 hour 17 minutes ago Focus Graphite Advanced Materials Initiates Validation Testing of Lac Knife Anode Materials with Leading Battery Innovator C4V
Published on 04/03/2025 at 05:10, 7 hours 7 minutes ago Battery X Metals Announces Corporate Awareness Agreement
Published on 04/03/2025 at 01:35, 10 hours 42 minutes ago GMV Minerals Inc. Closes Non-Brokered Financing/ Engages Investor Relations Firm
Published on 04/02/2025 at 23:35, 12 hours 42 minutes ago Murchison Minerals to Seek Shareholders’ Approval for Share Consolidation
Published on 04/02/2025 at 20:00, 16 hours 17 minutes ago Network-1 Announces Acquisition of Patent Portfolio
Published on 04/03/2025 at 12:00, 17 minutes ago Linde Announces First Quarter 2025 Earnings and Conference Call Schedule
Published on 04/03/2025 at 11:42, 35 minutes ago Resolutions of the 2025 annual general meeting of Ørsted A/S
Published on 04/03/2025 at 09:00, 3 hours 17 minutes ago Partners Group to invest in Gestcompost, the largest organic waste manager in Spain, through a continuation fund
Published on 04/03/2025 at 09:00, 3 hours 17 minutes ago Upward trends in Europe – growing investor interest?
Published on 04/03/2025 at 09:45, 2 hours 31 minutes ago GUILLEMOT CORPORATION: Information regarding the total number of voting rights and shares 31/03/2025
Published on 04/03/2025 at 09:35, 2 hours 41 minutes ago Disclosure of Share Capital and Voting Rights as of March 31, 2025
Published on 04/03/2025 at 08:45, 3 hours 32 minutes ago Baikowski: Strong growth in 2024 full-year results
Published on 04/03/2025 at 08:00, 4 hours 17 minutes ago Availability of preparatory documents for the Annual Shareholders’ Meeting of OPmobility SE
Published on 04/03/2025 at 00:37, 11 hours 40 minutes ago Publication of the report on payments made to governments provided by article L.225-102-3 of the French Commercial Code
